cancer. Neoplasm related pain (acute) (chronic)
Conditions
Interventions
Intervention 1: Intervention group: Standard Jensing Extract 250 mg, Gol daru Factory, once a day. Intervention 2: Control group: Capsules of the same color and shape and size with the main drug fille
Treatment - Drugs
Placebo
Intervention group: Standard Jensing Extract 250 mg, Gol daru Factory, once a day
Control group: Capsules of the same color and shape and size with the main drug filled with placebo (wheat flour)
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: A definitive diagnosis of cancer according to the opinion of the oncologist Patients who are at stage II and I of the disease. Patients with colorectal cancer or stomach cancer Having a sleep disorder Having pain
Exclusion criteria
Exclusion criteria: Use of anesthetics and narcotic drugs during study Participant's unwillingness to continue participating in the study Mental illness that is mentioned in the medical history of the patient. Receiving sleep disturbances such as diuretic drugs, antidepressants, inotropes and amphetamines at night Need for cardiopulmonary resuscitation during the intervention Mental disabilities Taking anti-coagulant drugs such as warfarin or aspirin Having diabetes and receiving anti-diabetes treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain based on scale vas. Timepoint: Before the intervention, 30 days after the intervention. Method of measurement: scale VAS. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sleep quality based on Pittsburgh scale. Timepoint: Before the intervention, 30 days after the intervention. Method of measurement: Pittsburgh scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactAzad Rahmani
Tabriz University of Medical Sciences
Outcome results
None listed